Surveillance for vancomycin-resistant enterococci: Type, rates, costs, and implications

Authors

Brooke N. Shadel, Saint Louis University, School of Public Health
Laura A. Puzniak, Saint Louis University, School of Public Health
Kathleen N. Gillespie, Saint Louis University, School of Public HealthFollow
Steven J. Lawrence, Washington University School of Medicine in St. Louis
Marin Kollef, Washington University School of Medicine in St. LouisFollow
Linda M. Mundy, Saint Louis University, School of Public Health

Journal

Infection Control and Hospital Epidemiology

Publication Date

2006

Volume

27

Issue

10

Inclusive Pages

1068-1075

Document Type

Open Access Publication

DOI

10.1086/507960

Rights and Permissions

Surveillance for Vancomycin‐Resistant Enterococci: Type, Rates, Costs, and Implications •  Brooke N. Shadel , PhD, MPH, Laura A. Puzniak , PhD, MPH, Kathleen N. Gillespie , PhD, Steven J. Lawrence , MD, Marin Kollef , MD and Linda M. Mundy , MD Infection Control and Hospital Epidemiology , Vol. 27, No. 10 (October 2006), pp. 1068-1075 Published by: The University of Chicago Press on behalf of The Society for Healthcare Epidemiology of America Article DOI: 10.1086/507960 Article Stable URL: http://www.jstor.org/stable/10.1086/507960

Recommended Citation

Shadel, Brooke N.; Puzniak, Laura A.; Gillespie, Kathleen N.; Lawrence, Steven J.; Kollef, Marin; and Mundy, Linda M., "Surveillance for vancomycin-resistant enterococci: Type, rates, costs, and implications." Infection Control and Hospital Epidemiology. 27, 10. 1068-1075. (2006).
https://digitalcommons.wustl.edu/open_access_pubs/914